Related Experiment Video
Updated: Aug 17, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Abstract:
2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido-[5,4-d]-pyrimidine (dipyridamole) induced interferon production in vitro in explanted mouse peritoneal leukocytes and to a lower degree in non-lymphoidal cell cultures of mouse (L cells primary embryo fibroblasts) and human (diploid embryo lung fibroblasts) origin. Dipyridamole induced interferon also in mice after intravenous administration. Peak interferon levels in the blood (128 IU/ml) were attained at 49 hr after injection of 0.1 mg dipyridamole per kg body weight and at 24 and 12 hr after injection of 0.6-1.8 and 16.7 mg/kg respectively. By its pH stability, thermostability and antigenic properties the interferon induced in mice, mouse peritoneal leukocytes and L cells corresponded to IFN-alpha and IFN-beta. This interferon-inducing capacity of dipyridamole may account for its broad-spectrum antiviral effect.
Insights
Dipyridamole, a compound, stimulates interferon production in various cells and in mice. This interferon, identified as IFN-alpha and IFN-beta, may explain dipyridamole's antiviral properties.
Area of Science:
- Immunology
- Virology
- Pharmacology
Background:
- Interferons (IFNs) are crucial cytokines in the innate immune response against viral infections.
- Dipyridamole is a vasodilator with potential immunomodulatory effects.
Purpose of the Study:
- To investigate the capacity of dipyridamole to induce interferon production.
- To characterize the type of interferon induced by dipyridamole.
Main Methods:
- In vitro induction of interferon using dipyridamole in mouse peritoneal leukocytes and non-lymphoid cell cultures (mouse L cells, human fibroblasts).
- In vivo induction of interferon in mice following intravenous administration of dipyridamole.
- Characterization of induced interferon based on pH stability, thermostability, and antigenic properties.
Main Results:
- Dipyridamole induced interferon production in vitro in mouse peritoneal leukocytes and, to a lesser extent, in mouse L cells and human diploid embryo lung fibroblasts.
- Intravenous administration of dipyridamole induced interferon in mice, with peak levels dependent on dosage.
- The induced interferon exhibited properties consistent with IFN-alpha and IFN-beta.
Conclusions:
- Dipyridamole possesses interferon-inducing capabilities.
- The interferon induced by dipyridamole is characterized as IFN-alpha and IFN-beta.
- This interferon-inducing property may underlie dipyridamole's broad-spectrum antiviral activity.
Related Concept Videos
Experimental RNAi
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Dipeptidyl Peptidase 4 Inhibitors
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly

